Vol 55, No 3 (2024)
Short communication
Published online: 2024-06-28

open access

Page views 95
Article views/downloads 38
Get Citation

Connect on Social Media

Connect on Social Media

Hepatitis E virus markers in hematological patients in highly endemic country

Aleksandra Kalińska1, Justyna Śledź1, Kazimierz Hałaburda2, Barbara Nasiłowska-Adamska2, Bernadeta Ceglarek3, Harry Dalton4, Jerzy Jaroszewicz5, Piotr Grabarczyk1
DOI: 10.5603/ahp.100012
Acta Haematol Pol 2024;55(3):180-184.

Abstract

< p > < /p >

Article available in PDF format

View PDF Download PDF file

References

  1. Dalton H, Kamar N, Baylis S, et al. EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol. 2018; 68(6): 1256–1271.
  2. Mikulska M, Penack O, Wendel L, et al. HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working Party. Bone Marrow Transplant. 2022; 57(2): 167–175.
  3. Cruz S, Campos C, Timóteo M, et al. Hepatitis E virus in hematopoietic stem cell transplant recipients: A systematic review. J Clin Virol. 2019; 119: 31–36.
  4. Gallian P, Pouchol E, Djoudi R, et al. Transfusion-transmitted hepatitis E virus infection in France. Transfus Med Rev. 2019; 33(3): 146–153.
  5. Gallian P, Lhomme S, Morel P, et al. Risk for hepatitis E virus transmission by solvent/detergent-treated plasma. Emerg Infect Dis. 2020; 26(12): 2881–2886.
  6. Damiris K, Aghaie Meybodi M, Niazi M, et al. Hepatitis E in immunocompromised individuals. World J Hepatol. 2022; 14(3): 482–494.
  7. Yin X, Li X, Feng Z. Role of envelopment in the HEV life cycle. Viruses. 2016; 8(8): 229.
  8. Behrendt P, Friesland M, Wißmann JE, et al. Hepatitis E virus is highly resistant to alcohol-based disinfectants. J Hepatol. 2022; 76(5): 1062–1069.
  9. Johne R, Trojnar E, Filter M, et al. Thermal stability of hepatitis E virus as estimated by a cell culture method. Appl Environ Microbiol. 2016; 82(14): 4225–4231.
  10. Buescher G, Ozga AK, Lorenz E, et al. Hepatitis E seroprevalence and viremia rate in immunocompromised patients: a systematic review and meta-analysis. Liver Int. 2021; 41(3): 449–455.
  11. Grabarczyk P, Sulkowska E, Gdowska J, et al. Molecular and serological infection marker screening in blood donors indicates high endemicity of hepatitis E virus in Poland. Transfusion. 2018; 58(5): 1245–1253.
  12. Chiu CY, Zhang HC, Westin J, et al. Hepatitis E virus infection in cancer patients. Transplant Cell Ther. 2022; 28(11): 788.e1–788.e5.
  13. Swartling L, Nordén R, Samuelsson E, et al. Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2020; 55(7): 1255–1263.
  14. Holm DK, Moessner BK, Engle RE, et al. Declining prevalence of hepatitis E antibodies among Danish blood donors. Transfusion. 2015; 55(7): 1662–1667.
  15. Gravemann U, Engelmann M, Kinast V, et al. Hepatitis E virus is effectively inactivated by methylene blue plus light treatment. Transfusion. 2022; 62(11): 2200–2204.
  16. Praditya D, Friesland M, Gravemann U, et al. Hepatitis E virus is effectively inactivated in platelet concentrates by ultraviolet C light. Vox Sang. 2020; 115(7): 555–561.
  17. Owada T, Kaneko M, Matsumoto C, et al. Establishment of culture systems for genotypes 3 and 4 hepatitis E virus (HEV) obtained from human blood and application of HEV inactivation using a pathogen reduction technology system. Transfusion. 2014; 54(11): 2820–2827.
  18. Antoniewicz-Papis J, Brojer E, Fabijańska-Mitek J, et al. Current status and achievements of Polish transfusion medicine. Acta Haematol Pol. 2021; 52(3): 147–162.
  19. von Felden J, Alric L, Pischke S, et al. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study. J Hepatol. 2019; 71(3): 465–472.